Article Details
Retrieved on: 2024-11-12 19:29:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
Article found on: www.patientcareonline.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here